tologically a low-grade angiosarcoma. There are less than 200 cases of tumorous PASH and less than 20 of diffuse PASH reported so far. Here we present a case report of huge diffuse PASH, that is, to our knowledge, the first in a pregnant woman.
Introduction
Pseudoangiomatous stromal hyperplasia (PASH) is a benign proliferation of the breast stroma mostly described as an incidental pathologic finding associated with several breast entities like fibrocystic changes, fibroadenomas, gynaecomastia or breast cancer [1] . This condition rarely occurs as a clinically apparent mammary lesion originally described in 1986 by Vuitch et al. [2] . A typical clinKeywords Diffuse pseudoangiomatous stromal hyperplasia · PASH · Pregnancy · Breast · Mastectomy Summary Pseudoangiomatous stromal hyperplasia (PASH) is a benign proliferation of mammary stroma mostly described as an incidental microscopic finding. Clinically, it can manifest as a palpable, well-circumscribed breast mass or in rare cases as a diffuse bilateral process causing massive breast enlargement. The most postulated theory for aetiology of this condition is hormonal stimulation of mammary myofibroblasts, particularly by progesterone. A definite diagnosis of PASH is based on typical pathological findings like stromal hyperplasia and empty slit-like channels positive for myofibroblastic and negative for endothelial markers. The main clinical differential diagnosis is a fibroadedoma or phylloid tumour, and his- ical manifestation is a unilateral breast mass, mostly mimicking a fibroadenoma (nodular PASH). In very rare cases PASH presents as bilateral diffuse process leading to rapid breast enlargement without discrete nodular mass (diffuse PASH). Less than 200 cases of nodular PASH and less than 20 of rapidly growing diffuse PASH have been reported in the literature so far, to our knowledge, none of them in a pregnant woman [3] [4] [5] .
Case Report
A 33-year-old primigravida at 14 weeks of dichorionic diamniotic twin pregnancy presented at our department with massive bilateral breast enlargement within the first trimester of gestation. The patient reported breast tenderness, back pain with movement limitation and respiratory impairment. Her previous medical conditions included bronchial asthma. Physical examination revealed bilateral asymmetric gigantomastia, with the right breast being larger than the left, diffuse lymphoedema and multiple skin ulcerations ( fig. 1 ). No isolated mammary nodules were palpable. Bilateral diagnostic excisional biopsies performed at another hospital showed diffuse PASH of both breasts. The patient was referred to our certified breast cancer centre for further evaluation. A breast ultrasound showed increased breast density with pronounced lymphoedema without circumscribed nodular lesions. No local lymphadenopathy was found. A breast magnetic resonance imaging demonstrated massive lymphoedema with distinctive thickening of the skin and subcutaneous tissue and no circumscribed mass lesions ( fig. 2 ). Due to rapid progression of the macromastia, resulting in worsening of the respiratory impairment and pain, a bilateral skin-sparing mastectomy with immediate reconstruction was performed at 16 weeks of the pregnancy. Bilateral mastectomy specimens (7,273 g right and 5,504 g left) were removed ( fig. 3 ). Histological tissue examination revealed typical characteristics of PASH-like stromal hyperplasia and slit-like spaces lined by endothelial-like spindle cells (fig. 4) . Moreover, stromal oedema, necrosis, fibrous mastopathy, adedosis and epidermoid cysts were found in both breasts. The further course of pregnancy was uneventful; healthy twins were delivered by caesarean section at 38 weeks of gestation.
Discussion
PASH represents hyperplasia of mammary stroma commonly accompanying benign and malignant breast entities. As demonstrated by Ibrahim et al. [1] , incidental microscopic PASH can be found in up to 23% of consecutive breast specimens. In contrast, clinically manifest PASH as a main pathological finding is a rare entity. Typically it forms a solitary, unilateral, well-circumscribed mass that mostly mimics a fibroadenoma or phylloid tumour. In rare cases it can appear bilaterally forming diffuse multiple tumours and leading to massive asymmetric breast enlargement. On rare occasions this phenomenon can occur without formation of the obvious tumour mass, as presented in our patient [6] . Although no definite mechanism of PASH has yet been identified, the most accepted theory for the aetiology and pathogenesis of this condition is a hormonal stimulation of mammary myofibroblasts. This hypothesis is supported by the fact that the majority of PASH cases show oestrogen receptor and most of all progesterone receptor positivity of stromal cells [7, 8] . This findings correspond to clinical observations that PASH mostly occurs in premenopausal women or postmenopausal women who received hormone replacement therapy. A dominant role of progesterone could also explain the rapid breast enlargement in our patient during first trimester of the pregnancy. However, there are also rare reports of PASH in children or postmenopausal women with no exogenous hormonal influence [9] [10] [11] .
While the clinical manifestation of PASH may vary widely between patients, definite diagnosis is based on typical histological findings, such as empty slit-like spaces formed in acellular dense collagenous stroma lined by spindle cells and imitating blood vessels [6] . Immunohistochemical positivity for CD34, vimentin or smooth muscle actin supports the myofibroblastic origin of these cells, whereas negativity for endothelial markers such as CD31 and von Willebrand factor helps the distinction from low-grade angiosarcoma, the main microscopic differential diagnosis of PASH [1, 6, 8] .
PASH is a benign condition with excellent prognosis. Incidental PASH does not require any additional treatment and tumorous PASH is treated by local excision with clear margins. However, the very rare diffuse PASH with massive breast enlargement requires uni-or bilateral mastectomy as in our patient and other reported cases [3] [4] [5] . The risk of recurrence after surgical excision is up to 22% [6, 12] . There is no established conservative therapy for PASH, although a single case of successful treatment with tamoxifen has been reported by Pruthi and colleagues [13] . PASH is not considered a premalignant lesion or a risk factor for a breast cancer [12, 14] .
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